Cryoport CYRX
$19.10 +$3.05 (+19.00%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $19.00 -0.52%
Open$17.50
Prev close$16.05
Day range$17.17 – $19.53
Volume2.59M
Market cap$968.38M
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q2, ended Jun 2026
Revenue$48.97M+7.7% YoY
Operating profit-$10.04M-4.0% YoY
Net profit-$8.26M-107.6% YoY
Diluted EPS-$0.20-109.4% YoY
Free cash flow-$8.68M+35.9% YoY
Operating cash flow$1.13M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin47.1%
Operating margin-21.2%
Net margin-24.3%
Return on equity-9.9%
Return on assets-5.9%
Return on invested capital-6.4%
Current ratio2.08
Liabilities / assets35.1%
Cash & investments$396.69M
Total debt$227.63M
Net cash (debt)$169.06M
Where the revenue comes from
Quarter 2026/Q2
By business line
Income statement
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $48.97M | $47.80M | $176.18M | $45.45M | $44.23M |
| Total Operating Revenue | $48.97M | $47.80M | $176.18M | $45.45M | $44.23M |
| Cost of Revenue | $26.15M | $25.89M | $93.12M | $23.74M | $22.91M |
| Gross Profit | $22.82M | $21.91M | $83.05M | $21.71M | $21.33M |
| Operating Expense | $32.86M | $31.53M | $119.86M | $31.74M | $31.26M |
| Selling and Admin Expenses | $28.01M | $27.62M | $102.82M | $27.28M | $26.73M |
| Research & Development | $4.85M | $3.91M | $17.04M | $4.47M | $4.52M |
| Operating Profit | -$10.04M | -$9.61M | -$36.81M | -$10.03M | -$9.93M |
| Net Non-Operating Interest Income (Expense) | -$518,000.00 | -$432,000.00 | -$2.36M | -$634,000.00 | -$526,000.00 |
| Non-Operating Interest Expense | $518,000.00 | $432,000.00 | $2.36M | $634,000.00 | $526,000.00 |
| Other Income (Expense) | $2.81M | $722,000.00 | $7.00M | $3.27M | $3.93M |
| Gain on Sale of Security | $3.13M | $3.09M | $9.80M | $3.36M | $3.40M |
| Other Non-Operating Income (Expenses) | -$325,000.00 | -$2.37M | -$2.80M | -$87,000.00 | $525,000.00 |
| Pretax Profit | -$7.75M | -$9.32M | -$32.17M | -$7.40M | -$6.53M |
| Tax | $505,000.00 | $108,000.00 | $1.80M | $1.13M | $165,000.00 |
| Net Profit | -$8.26M | -$10.54M | $78.30M | -$11.64M | -$6.94M |
| Profit from Continuing Operations | -$8.26M | -$9.43M | -$33.97M | -$8.52M | -$6.70M |
| Net Income from Discontinuous Operations | $0.00 | -$1.11M | $112.27M | -$3.12M | -$247,000.00 |
| Net Income to Parent Company | -$8.26M | -$10.54M | $78.30M | -$11.64M | -$6.94M |
| Preferred Stock Dividends | $2.00M | $2.00M | $8.00M | $2.00M | $2.00M |
| Net Income to Common Stockholders | -$10.26M | -$12.54M | $70.30M | -$13.64M | -$8.94M |
| Basic EPS | -$0.20 | -$0.25 | $1.40 | -$0.27 | -$0.18 |
| Diluted EPS | -$0.20 | -$0.25 | $1.40 | -$0.27 | -$0.18 |
| Special Income (Charges) | – | – | $0.00 | $0.00 | $0.00 |
| -Less:Impairment of Capital Assets | – | – | $0.00 | – | – |
| -Less:Write Off | – | – | – | – | $0.00 |
Balance sheet
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $756.20M | $763.61M | $764.99M | $764.99M | $774.33M |
| Total Current Assets | $460.20M | $470.54M | $476.17M | $476.17M | $484.84M |
| Cash and Cash Equivalents & Short-Term Investments | $396.69M | $403.63M | $411.21M | $411.21M | $421.31M |
| -Cash and Cash Equivalents | $269.27M | $272.91M | $250.49M | $250.49M | $255.81M |
| -Short Term Investments | $127.43M | $130.72M | $160.71M | $160.71M | $165.50M |
| Receivables | $36.45M | $39.00M | $33.36M | $33.36M | $34.91M |
| -Accounts Receivable | $36.45M | $39.00M | $33.36M | $33.36M | $34.91M |
| Inventory | $21.51M | $21.75M | $23.19M | $23.19M | $23.33M |
| Other Current Assets | $5.55M | $6.15M | $8.42M | $8.42M | $5.29M |
| Total Non-Current Assets | $296.00M | $293.07M | $288.82M | $288.82M | $289.49M |
| Net PPE | $134.84M | $129.10M | $125.17M | $125.17M | $123.46M |
| -Gross PPE | $134.84M | $129.10M | $174.65M | $174.65M | $123.46M |
| Non-Current Prepaid Assets | $2.04M | $2.05M | $2.09M | $2.09M | $2.10M |
| Goodwill and Other Intangible Assets | $158.06M | $160.86M | $160.48M | $160.48M | $163.66M |
| -Goodwill | $22.07M | $22.14M | $22.40M | $22.40M | $22.41M |
| -Other Intangible Assets | $135.99M | $138.72M | $138.08M | $138.08M | $141.25M |
| Non-Current Deferred Assets | $1.06M | $1.07M | $1.07M | $1.07M | $268,000.00 |
| Total Liabilities | $265.51M | $268.62M | $262.35M | $262.35M | $261.06M |
| Total Current Liabilities | $221.04M | $224.87M | $219.02M | $219.02M | $30.75M |
| Payables | $16.25M | $15.94M | $15.28M | $15.28M | $13.88M |
| -Accounts Payable | $16.25M | $15.94M | $15.28M | $15.28M | $13.88M |
| Short-Term Debt and Capital Lease Obligation | $190.23M | $189.61M | $189.81M | $189.81M | $4.55M |
| -Current Debt | $185.85M | $185.55M | $185.26M | $185.26M | – |
| -Current Capital Lease Obligation | $4.39M | $4.06M | $4.56M | $4.56M | $4.55M |
| Current Deferred Liabilities | $1.72M | $2.31M | $943,000.00 | $943,000.00 | $1.45M |
| Other Current Liabilities | $652,000.00 | – | – | – | – |
| Total Non-Current Liabilities | $44.47M | $43.75M | $43.33M | $43.33M | $230.31M |
| Long Term Debt and Capital Lease Obligation | $41.79M | $40.88M | $40.91M | $40.91M | $226.31M |
| -Long Term Debt | $985,000.00 | $1.03M | $1.09M | $1.09M | $186.09M |
| -Long Term Capital Lease Obligation | $40.80M | $39.85M | $39.82M | $39.82M | $40.22M |
| Non-Current Deferred Liabilities | $1.85M | $1.58M | $1.35M | $1.35M | $664,000.00 |
| Other Non-Current Liabilities | $832,000.00 | $1.29M | $1.07M | $1.07M | $3.34M |
| Total Equity | $490.70M | $494.99M | $502.64M | $502.64M | $513.27M |
| Stockholders' Equity | $490.70M | $494.99M | $502.64M | $502.64M | $513.27M |
| Capital Stock | $46.33M | $44.33M | $42.33M | $42.33M | $40.33M |
| -Common Stock | $51,000.00 | $50,000.00 | $50,000.00 | $50,000.00 | $50,000.00 |
| -Preferred Stock | $46.28M | $44.28M | $42.28M | $42.28M | $40.28M |
| Additional Paid-In Capital | $1.15B | $1.15B | $1.15B | $1.15B | $1.15B |
| Retained Earnings | -$707.68M | -$699.43M | -$688.88M | -$688.88M | -$675.24M |
| Gains/Losses Not Affecting Retained Earnings | -$2.45M | -$3.21M | -$3.48M | -$3.48M | -$4.07M |
| -Accumulated Depreciation | – | – | -$49.48M | -$49.48M | – |
| Current Accrued Expenses | – | – | $9.63M | $9.63M | – |
Cash flow
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.13M | $3.74M | -$8.58M | $919,000.00 | $2.19M |
| Net cash flow from continuing operations | $1.13M | $3.74M | -$8.58M | $919,000.00 | $2.19M |
| Net Income from Continuing Operations | -$8.26M | -$10.54M | $78.30M | -$11.64M | -$6.94M |
| Gain/Loss from Continuing Operations | $416,000.00 | $1.07M | -$113.73M | $3.88M | $743,000.00 |
| Depreciation & Depletion & Amortization | $6.59M | $6.40M | $27.71M | $6.36M | $6.42M |
| Other Non-Cash Items | $1.42M | $1.65M | $3.31M | $2.02M | $1.82M |
| Change in Working Capital | -$851,000.00 | $1.69M | -$13.69M | -$2.28M | -$1.32M |
| -Change in Receivables | $2.59M | -$5.73M | -$6.53M | $1.30M | -$1.88M |
| -Change in Inventory | $352,000.00 | $1.32M | -$2.19M | -$97,000.00 | -$421,000.00 |
| -Change in Prepaid Assets | $589,000.00 | $2.24M | $1.16M | -$3.17M | $1.32M |
| -Change in Payables and Accrued Expense | -$2.99M | $3.47M | -$1.56M | $1.38M | $1.23M |
| -Change in Other Current Liabilities | -$1.07M | -$1.21M | -$5.04M | -$1.07M | -$1.03M |
| -Change In Other Working Capital | -$325,000.00 | $1.62M | $445,000.00 | -$621,000.00 | -$530,000.00 |
| Net cash flow from investing | -$5.81M | $18.72M | $250.32M | $56,000.00 | $14.31M |
| Net Cash Flow from Continuing Investing Activities | -$5.81M | $18.72M | $250.32M | $56,000.00 | $14.31M |
| Net PPE Purchase and Sale | -$9.10M | -$9.98M | -$16.44M | -$5.47M | -$3.45M |
| Net Intangibles Purchase and Sale | -$710,000.00 | -$301,000.00 | -$3.07M | $523,000.00 | -$829,000.00 |
| Net Investment Purchase and Sale | $4.00M | $29.00M | $59.59M | $5.00M | $18.59M |
| Financing Cash Flow | $653,000.00 | $85,000.00 | -$21.07M | -$2.15M | -$2.87M |
| Net Cash Flow from Continuing Financing Activities | $653,000.00 | $85,000.00 | -$21.07M | -$2.15M | -$2.87M |
| Net Issuance Payments Of Debt | -$148,000.00 | -$144,000.00 | -$15.04M | -$145,000.00 | -$146,000.00 |
| Proceeds from Stock Option Exercised | $801,000.00 | $229,000.00 | $3.97M | -$1,000.00 | $1.02M |
| Ending Cash Balance | $269.27M | $272.91M | $250.49M | $250.49M | $255.81M |
| Net Change in Cash | -$4.03M | $22.54M | $220.67M | -$1.18M | $13.63M |
| Beginning Cash Balance | $272.91M | $250.49M | $45.29M | $255.81M | $243.42M |
| Effect of Exchange Rate Changes | $384,000.00 | -$120,000.00 | -$15.46M | -$4.14M | -$1.23M |
| Free Cash Flow | -$8.68M | -$6.55M | -$28.09M | -$4.03M | -$2.09M |
| Net Business Purchase and Sale | – | – | $210.24M | $0.00 | $0.00 |
| Net Common Stock Issuance | – | – | -$10.01M | -$2.01M | -$3.75M |
No comments yet — be the first to weigh in on CYRX.